glp 1 class of drugs Dosage GLP-1 analogues Classification of glucagon-like peptide-1 receptor

It is closer to the injectable semaglutide range than to tirzepatide

Mechanisms of NAFLD Development and Therapeutic Strategies

Trejeeve (Tre) Martyn, Beyond Diabetes: A Review of Emerging Indications for Glucagon-Like Peptide-1 Receptor Agonists, we highlight how these therapies are reshaping care across the cardiometabolic spectrum, including obesity, ASCVD, HFpEF, CKD, MASLD/MASH, and obstructive sleep apnea

Ghosal S, Datta D, Sinha B (2021) A meta-analysis of the effects of glucagon-like-peptide 1 receptor agonist (GLP1-RA) in nonalcoholic fatty liver disease (NAFLD) with type 2 diabetes (T2D)

Intuitive Surgical also saw shares slide when executives noted slowed growth in bariatric surgeries last quarter, potentially due to increased use of GLP-1 drugs

In addition to achieving significant weight loss, research has shown that GLP-1 drugs can reduce the risk of major cardiovascular events such as heart attack or stroke in people with Type 2 diabetes